FDA

Arrows pointing the way of up and down
Biotech

Not a straight line: Biotech finds resilience in tumultuous year

Ten months into 2025, and it’s clear the year hasn’t unfolded as many had expected—or hoped.
Gabrielle Masson Oct 10, 2025 10:44am
end of the road road block shut down closed blocked

FDA snubs Fortress' Zydus-partnered Menkes disease candidate

Oct 1, 2025 12:00pm
MRI scan

Siemens Healthineers’ MRIs see FDA recall over ice blockages

Oct 1, 2025 10:30am
Biolinq wearable on inside forearm

FDA clears Biolinq's color-coded sensor patch for glucose ranges

Sep 29, 2025 11:30am
Stock decreasing graphic

Applied Tx's stock drops on non-update for rare disease asset

Sep 29, 2025 10:57am
Essilor Luxottica Stellest expo booth

FDA clears 1st eyeglasses for slowing childhood nearsightedness

Sep 26, 2025 11:38am